Stock Price
1,187.65
Daily Change
5.15 0.44%
Monthly
-3.86%
Yearly
-0.34%
Q1 Forecast
1,189.51

Aurobindo Pharma reported INR8.48B in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Cipla INR 6.76B 6.75B Dec/2025
Divis Laboratories Ltd INR 6.89B 1.44B Sep/2025
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Hindustan Unilever INR 26.85B 710M Sep/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
UPL INR 3.96B 1.57B Dec/2025